SNOA
Sonoma Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
SNOA fundamentals
Sonoma Pharmaceuticals (SNOA) released its earnings on Aug 7, 2025: revenue was 4.01M (YoY +18.40%), missed estimates; EPS was -0.3694 (YoY +70.80%), beat estimates.
Revenue / YoY
4.01M
+18.40%
EPS / YoY
-0.3694
+70.80%
Report date
Aug 7, 2025
Earnings
EPS
Revenue
Revenue & Expenses
SNOA has released its 2026 Q3 earnings report, with revenue of 4.35M, reflecting a YoY change of 22.03%, and net profit of -819.00K, showing a YoY change of 11.75%. The Sankey diagram below clearly presents SNOA's revenue sources and cost distribution.
Key Indicators
Sonoma Pharmaceuticals (SNOA) key financial stats and ratios, covering profitability, financial health, and leverage.
Income Statement
Sonoma Pharmaceuticals (SNOA)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Balance Sheet
Sonoma Pharmaceuticals (SNOA)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cash Flow
Sonoma Pharmaceuticals (SNOA)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Revenue Breakdown
Where does Sonoma Pharmaceuticals (SNOA) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Dividend
Track Sonoma Pharmaceuticals (SNOA) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is the revenue and EPS growth rate for Sonoma Pharmaceuticals year over year?What factors drove the changes in Sonoma Pharmaceuticals's revenue and profit?What were the key takeaways from Sonoma Pharmaceuticals’s earnings call?Did Sonoma Pharmaceuticals beat or miss consensus estimates last quarter?What guidance did Sonoma Pharmaceuticals's management provide for the next earnings period?What is Sonoma Pharmaceuticals's gross profit margin?What were the key takeaways from Sonoma Pharmaceuticals's earnings call?What is the market's earnings forecast for Sonoma Pharmaceuticals next quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
